Skip to content

Lab‑Made Heart Valve Tissue Could Transform Treatment for Young Patients

By News Analysis India · · 1 min read

A team of scientists in Melbourne has successfully engineered heart‑valve tissue from pluripotent stem cells that replicates the mechanical and biological properties of a human valve. The breakthrough, reported in *Cell Stem Cell*, could pave the way for biologically compatible valve replacements that grow with the patient.

The researchers grew the tissue in a specialised bioreactor that mimics the heart’s pressure and flow. Over weeks, the cells organised into leaf‑like structures that opened and closed like a natural valve. When implanted in laboratory models, the tissue integrated with surrounding cardiac tissue and showed normal physiological performance.

Heart‑valve disease affects an estimated 28 million individuals globally. In children, the rapid growth of the heart often renders conventional prosthetic valves unsuitable, forcing multiple surgeries. By using a patient’s own stem cells, the new approach may eliminate the need for lifelong anticoagulation therapy and reduce the risk of rejection.

The study also demonstrated the model’s utility for disease research. When exposed to rheumatic fever‑associated inflammatory proteins, the engineered valves hardened and expressed disease‑specific biomarkers, mirroring the pathology seen in rheumatic heart disease, a condition that remains a major health concern among Aboriginal Australians.

Professor Enzo Porello, senior author, emphasized that the technology could eventually produce “living valves that remodel in response to physiological demands”. Ongoing animal trials will assess durability, immune compatibility and functional longevity before human trials can begin.